BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31135239)

  • 1. Predictors of sick leave and improved worker productivity after 52 weeks of intensive treatment in patients with early rheumatoid arthritis.
    Blomjous BS; Boers M; Den Uyl D; Twisk J; Van Schaardenburg D; Voskuyl AE; Lems WF; Ter Wee MM
    Scand J Rheumatol; 2019 Jul; 48(4):271-278. PubMed ID: 31135239
    [No Abstract]   [Full Text] [Related]  

  • 2. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
    Landewé RB; Boers M; Verhoeven AC; Westhovens R; van de Laar MA; Markusse HM; van Denderen JC; Westedt ML; Peeters AJ; Dijkmans BA; Jacobs P; Boonen A; van der Heijde DM; van der Linden S
    Arthritis Rheum; 2002 Feb; 46(2):347-56. PubMed ID: 11840436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
    Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
    Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sick leave and work disability in patients with early arthritis.
    Zirkzee EJ; Sneep AC; de Buck PD; Allaart CF; Peeters AJ; Ronday HK; Westedt ML; le Cessie S; Vliet Vlieland TP
    Clin Rheumatol; 2008 Jan; 27(1):11-9. PubMed ID: 17492248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sick leave before and after diagnosis of rheumatoid arthritis--a report from the Swedish TIRA project.
    Björk M; Thyberg I; Rikner K; Balogh I; Gerdle B
    J Rheumatol; 2009 Jun; 36(6):1170-9. PubMed ID: 19411387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
    Neovius M; Simard JF; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Aug; 70(8):1407-14. PubMed ID: 21518724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of sick leave and reduced productivity at work among persons with early inflammatory joint conditions.
    Geuskens GA; Hazes JM; Barendregt PJ; Burdorf A
    Scand J Work Environ Health; 2008 Dec; 34(6):420-9. PubMed ID: 19137203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.
    Boers M; Kostense PJ; Verhoeven AC; van der Linden S;
    Arthritis Rheum; 2001 Oct; 44(10):2242-6. PubMed ID: 11665964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M;
    Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis.
    Olofsson T; Söderling JK; Gülfe A; Kristensen LE; Wallman JK
    Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1712-1716. PubMed ID: 29885037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sick leave as a predictor of job loss in patients with chronic arthritis.
    de Buck PD; de Bock GH; van Dijk F; van den Hout WB; Vandenbroucke JP; Vliet Vlieland TP
    Int Arch Occup Environ Health; 2006 Nov; 80(2):160-70. PubMed ID: 16710710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
    Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S
    JAMA Intern Med; 2013 Aug; 173(15):1407-14. PubMed ID: 23817631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs: A Retrospective Cohort Study.
    Vazquez-Villegas ML; Gamez-Nava JI; Celis A; Sanchez-Mosco D; de la Cerda-Trujillo LF; Murillo-Vazquez JD; Saldaña-Cruz AM; Alcaraz-Lopez MF; Diaz-Rizo V; Alvarez-Nemegyei J; Cardiel MH; Gonzalez-Lopez L
    J Clin Rheumatol; 2017 Oct; 23(7):376-382. PubMed ID: 28937473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
    Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review.
    Lenssinck ML; Burdorf A; Boonen A; Gignac MA; Hazes JM; Luime JJ
    Ann Rheum Dis; 2013 Apr; 72(4):493-505. PubMed ID: 23264343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work and sick leave among patients with early inflammatory joint conditions.
    Geuskens GA; Hazes JM; Barendregt PJ; Burdorf A
    Arthritis Rheum; 2008 Oct; 59(10):1458-66. PubMed ID: 18821663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
    Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
    Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson JÅ; Geborek P; Jacobsson LT; Askling J; Neovius M
    Ann Rheum Dis; 2014 May; 73(5):845-53. PubMed ID: 23520035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.